Introductory Chapter: Antiphospholipid Antibodies - A Laboratory Criterion for the Antiphospholipid Syndrome, but Also Bystanders in Infections, Cancer, and Other Conditions
Reference54 articles.
1. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis. 2006;4(2):295-306
2. Schreiber K, Sciascia S, de Groot PG, Devreese K, Jacobsen S, Ruiz-Irastorza G, et al. Antiphospholipid syndrome. Nature Reviews Disease Primers. 2018;4:18005
3. Thomas RH. Hypercoagulability syndromes. Archives of Internal Medicine. 2001;161(20):2433-2439
4. Marchetti T, Cohen M, de Moerloose P. Obstetrical antiphospholipid syndrome: From the pathogenesis to the clinical and therapeutic implications. Clinical & Developmental Immunology. 2013;2013:159124
5. Abreu MM, Danowski A, Wahl DG, Amigo M-C, Tektonidou M, Pacheco MS, et al. The relevance of “non-criteria” clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features. Autoimmunity Reviews. 2015;14(5):401-414